Gene · 7292
Papers4,164
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,164
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Atopic Dermatitis-Related Problems in Daily Life, Goals of Therapy and Deciding Factors for Systemic Therapy: A Review. | Pharmaceuticals (Basel) | 2024 | 39598368 | PubTator, text mining | PubMed |
| Anti-OX40 Biological Therapies in the Treatment of Atopic Dermatitis: A Comprehensive Review. | J Clin Med | 2024 | 39598069 | PubTator, text mining | PubMed |
| The Role of TNF Receptor-Associated Factor 5 in the Formation of Germinal Centers by B Cells During the Primary Phase of the Immune Response in Mice. | Int J Mol Sci | 2024 | 39596396 | PubTator, text mining | PubMed |
| A Narrative Review of the OX40-OX40L Pathway as a Potential Therapeutic Target in Atopic Dermatitis: Focus on Rocatinlimab and Amlitelimab. | Dermatol Ther (Heidelb) | 2024 | 39565527 | PubTator, text mining | PubMed |
| SHR-1806, a robust OX40 agonist to promote T cell-mediated antitumor immunity. | Cancer Biol Ther | 2024 | 39543823 | PubTator, text mining | PubMed |
| CAR-ving away OX40L with engineered Tregs. | Sci Immunol | 2024 | 39485860 | PubTator, text mining | PubMed |
| Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells. | Front Immunol | 2024 | 39474429 | PubTator, text mining | PubMed |
| Immune marker expression and prognosis of early breast cancer expressing HER3. | Eur J Cancer | 2024 | 39447449 | PubTator, text mining | PubMed |
| IL-33-primed human mast cells drive IL-9 production by CD4+ effector T cells in an OX40L-dependent manner. | Front Immunol | 2024 | 39416773 | PubTator, text mining | PubMed |
| Human OX40L-CAR-Tregs target activated antigen-presenting cells and control T cell alloreactivity. | Sci Transl Med | 2024 | 39413160 | PubTator, text mining | PubMed |
| Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC. | Front Oncol | 2024 | 39411143 | PubTator, text mining | PubMed |
| Research progress in OX40/OX40L in allergic diseases. | Int Forum Allergy Rhinol | 2024 | 39404736 | PubTator, text mining | PubMed |
| Emerging Biologic Therapies for the Treatment of Atopic Dermatitis. | Drugs | 2024 | 39365406 | PubTator, text mining | PubMed |
| Molecular mechanisms regulating T helper 2 cell differentiation and function. | Curr Opin Immunol | 2024 | 39357077 | PubTator, text mining | PubMed |
| Activation of NOD1 on tumor-associated macrophages augments CD8+ T cell-mediated antitumor immunity in hepatocellular carcinoma. | Sci Adv | 2024 | 39356756 | PubTator, text mining | PubMed |
| Tannic acid elicits differential gene regulation in prostate cancer apoptosis. | Acta Pharm | 2024 | 39279521 | PubTator, text mining | PubMed |
| NK Cell Degranulation Triggered by Rituximab Identifies Potential Markers of Subpopulations with Enhanced Cytotoxicity toward Malignant B Cells. | Int J Mol Sci | 2024 | 39201666 | PubTator, text mining | PubMed |
| Preliminary Data on SNP of Transplantation-Related Genes after Haploidentical Stem Cell Transplantation. | J Clin Med | 2024 | 39200825 | PubTator, text mining | PubMed |
| Molecular Pathways and Potential Therapeutic Targets of Refractory Asthma. | Biology (Basel) | 2024 | 39194521 | PubTator, text mining | PubMed |
| Epigenome-wide association study of prostate cancer in African American men identified differentially methylated genes. | Cancer Med | 2024 | 39162297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7292/papers?page=11